C4 THERAPEUTICS INC's ticker is CCCC and the CUSIP is 12529R107. A total of 114 filers reported holding C4 THERAPEUTICS INC in Q3 2022. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2023 | $63,748 | -45.7% | 20,302 | +2.0% | 0.00% | -100.0% |
| Q4 2022 | $117,392 | -32.9% | 19,897 | -0.4% | 0.00% | 0.0% |
| Q3 2022 | $175,000 | +18.2% | 19,970 | +1.4% | 0.00% | 0.0% |
| Q2 2022 | $148,000 | -68.2% | 19,688 | +2.6% | 0.00% | -66.7% |
| Q1 2022 | $465,000 | -29.7% | 19,181 | -6.6% | 0.00% | 0.0% |
| Q4 2021 | $661,000 | -30.1% | 20,532 | -2.9% | 0.00% | -40.0% |
| Q3 2021 | $945,000 | +29.5% | 21,146 | +9.6% | 0.01% | +150.0% |
| Q2 2021 | $730,000 | +217.4% | 19,297 | +210.2% | 0.00% | +100.0% |
| Q1 2021 | $230,000 | +11.7% | 6,220 | +0.3% | 0.00% | 0.0% |
| Q4 2020 | $206,000 | – | 6,204 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| COMMODORE CAPITAL LP | 481,094 | $21,495,000 | 5.67% |
| Soleus Capital Management, L.P. | 750,633 | $33,538,000 | 5.23% |
| Bain Capital Life Sciences Investors, LLC | 1,642,209 | $73,374,000 | 4.55% |
| RTW INVESTMENTS, LP | 2,494,965 | $111,475,000 | 1.68% |
| P.A.W. CAPITAL CORP | 40,000 | $1,787,000 | 1.59% |
| Perceptive Advisors | 2,258,566 | $100,913,000 | 1.47% |
| SPHERA FUNDS MANAGEMENT LTD. | 381,774 | $17,058,000 | 1.43% |
| CLOUGH CAPITAL PARTNERS L P | 347,500 | $15,526,000 | 0.94% |
| HighVista Strategies LLC | 29,341 | $1,311,000 | 0.87% |
| RA Capital Management | 1,377,569 | $61,550,000 | 0.85% |